StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Vyndaqel Family (Vyndaqel / Vyndamax / Vynmac by Year

Vyndaqel Family (Vyndaqel / Vyndamax / Vynmac — ATTR-CM) — U.S. revenues ($M) ($M)

QuarterlyAnnual

Pfizer Vyndaqel Family (Vyndaqel / Vyndamax / Vynmac: $3,834M in FY2025, up 8.1% from a year earlier. That is the highest of the 8 years on record here.

Latest, FY2025
3,834
Period ended Dec 31, 2025
Change on a year earlier
+8.1%
3,547 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Vyndaqel family (e) | 6,380 | 5,451 | 17% | 16% | 3,834 | 3,547 | 8% | 2,546 | 1,904 | 34% | 30%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVyndaqel Family (Vyndaqel / Vyndamax / Vynmac — ATTR-CM) — U.S. revenues ($M) ($M)Year on yearSource
FY2025Dec 31, 20253,834+8.1%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2024Dec 31, 20243,547+90.4%Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
FY2023Dec 31, 20231,863+504.9%Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
FY2022Dec 31, 2022308-37.8%Form 8-K (Earnings / Guidance Release) (pfe-12312023xex99.htm, filed 2024-01-30) ↗
FY2021Dec 31, 2021495+58.7%Form 8-K (Earnings / Guidance Release) (pfe-12312022xex99.htm, filed 2023-01-31) ↗
FY2020Dec 31, 2020312+186.2%Form 8-K (Earnings / Guidance Release) (pfe-12312021xex99.htm, filed 2022-02-08) ↗
FY2019Dec 31, 2019109+153.5%Form 8-K (Earnings / Guidance Release) (pfe-12312020xex99.htm, filed 2021-02-02) ↗
FY2018Dec 31, 201843–Form 8-K (Earnings / Guidance Release) (pfe-12312019xex99.htm, filed 2020-01-28) ↗

Breakdown

What makes up vyndaqel Family (Vyndaqel / Vyndamax / Vynmac

Cite this data

StockData. (2026). Pfizer Vyndaqel Family (Vyndaqel / Vyndamax / Vynmac ($M), annual FY2018–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/vyndaqel-us

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.